• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中国浙江省,肌肉减少症与非酒精性脂肪肝的存在有关:一项横断面观察性研究。

Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.

机构信息

Department of Geriatrics, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.

Zhejiang Provincial Key Laboratory for Diagnosis and Treatment of Aging and Physic-chemical Injury Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.

出版信息

BMC Geriatr. 2021 Jan 14;21(1):55. doi: 10.1186/s12877-020-01910-3.

DOI:10.1186/s12877-020-01910-3
PMID:33446095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807816/
Abstract

BACKGROUND

Currently, both non-alcoholic fatty liver disease (NAFLD) and sarcopenia have attracted extensive attention in public health. However, the relationship between NAFLD and sarcopenia remains unclear. This study aimed to clarify the sex-specific association between sarcopenia and NAFLD according to the Asian Working Group for Sarcopenia (AWGS).

METHODS

Dual-energy X-ray absorptiometry (DXA) and hepatic ultrasonography were measured in 578 participants (92 men and 486 women) during their annual health examinations. Multivariate logistic regression models were used to explore the association between NAFLD and sarcopenia with its two components.

RESULTS

A total of 154 participants (30 men and 124 women) had NAFLD. The prevalence of sarcopenia was higher among the participants with NAFLD than among those without NAFLD (men: 20.0% vs. 9.7%, P = 0.295, women: 15.3% vs. 8.0%, P = 0.019). Low muscle mass (LMM) was independently associated with NAFLD in both men and women (men: odds ratio [OR], 2.88; 95% confidence interval [CI] 1.52-5.46; women: OR, 2.08; 95% CI 1.63-2.67). However, low muscle strength (LMS) was independently associated with NAFLD only in male participants, with an OR of 1.15 (95% CI 1.02-1.28).

CONCLUSION

The occurrence of sarcopenia was associated with a higher risk of NAFLD, especially in men, as demonstrated by lower muscle mass and lower muscle strength.

摘要

背景

目前,非酒精性脂肪性肝病(NAFLD)和肌少症均受到公众健康的广泛关注。然而,NAFLD 和肌少症之间的关系尚不清楚。本研究旨在根据亚洲肌少症工作组(AWGS)阐明肌少症与 NAFLD 之间的性别特异性关联。

方法

在年度健康检查中,使用双能 X 射线吸收法(DXA)和肝脏超声测量了 578 名参与者(92 名男性和 486 名女性)的数据。使用多变量逻辑回归模型探讨了 NAFLD 与肌少症及其两个组成部分之间的关系。

结果

共有 154 名参与者(30 名男性和 124 名女性)患有 NAFLD。患有 NAFLD 的参与者中肌少症的患病率高于未患有 NAFLD 的参与者(男性:20.0%比 9.7%,P=0.295,女性:15.3%比 8.0%,P=0.019)。低肌肉量(LMM)与男性和女性的 NAFLD 均独立相关(男性:比值比[OR],2.88;95%置信区间[CI],1.52-5.46;女性:OR,2.08;95%CI,1.63-2.67)。然而,低肌肉力量(LMS)仅与男性参与者的 NAFLD 独立相关,其 OR 为 1.15(95%CI,1.02-1.28)。

结论

肌少症的发生与 NAFLD 的风险增加相关,尤其是在男性中,表现为肌肉量和肌肉力量降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/5f968b993446/12877_2020_1910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/5f968b993446/12877_2020_1910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg

相似文献

1
Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.在中国浙江省,肌肉减少症与非酒精性脂肪肝的存在有关:一项横断面观察性研究。
BMC Geriatr. 2021 Jan 14;21(1):55. doi: 10.1186/s12877-020-01910-3.
2
The Relationship between NAFLD and Sarcopenia in Elderly Patients.非酒精性脂肪性肝病与老年患者肌少症的关系。
Can J Gastroenterol Hepatol. 2018 Mar 26;2018:5016091. doi: 10.1155/2018/5016091. eCollection 2018.
3
Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.非酒精性脂肪性肝病中肌少症及其定义成分的患病率因评估和调整方法而异:来自英国生物库的研究结果。
Calcif Tissue Int. 2024 Jun;114(6):592-602. doi: 10.1007/s00223-024-01212-5. Epub 2024 Apr 28.
4
Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.肌肉量低和肌肉力量低与非酒精性脂肪性肝病有关。
Clin Nutr. 2020 Apr;39(4):1124-1130. doi: 10.1016/j.clnu.2019.04.023. Epub 2019 Apr 25.
5
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.韩国成年人低骨骼肌量与非酒精性脂肪性肝病的关联:第五次韩国国家健康与营养检查调查
Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):39-47. doi: 10.1016/s1499-3872(15)60030-3.
6
Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).肌肉减少症是 COPD 患者非酒精性脂肪性肝病的独立危险因素:一项全国性调查(KNHANES 2008-2011)。
Int J Chron Obstruct Pulmon Dis. 2020 May 7;15:1005-1014. doi: 10.2147/COPD.S249534. eCollection 2020.
7
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.非酒精性脂肪肝疾病和肌肉减少症与心血管风险独立相关。
Am J Gastroenterol. 2020 Apr;115(4):584-595. doi: 10.14309/ajg.0000000000000572.
8
Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.非酒精性脂肪肝疾病对肌肉减少症风险的影响:一项全国多中心前瞻性研究。
Hepatol Int. 2022 Jun;16(3):545-554. doi: 10.1007/s12072-021-10258-8. Epub 2021 Nov 15.
9
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
10
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.肌肉减少症与2型糖尿病男性的非酒精性脂肪性肝病有关。
Diabetes Metab. 2020 Oct;46(5):362-369. doi: 10.1016/j.diabet.2019.10.004. Epub 2019 Nov 2.

引用本文的文献

1
Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia.解析代谢相关脂肪性肝病(MAFLD)与肌肉减少症之间的代谢途径
Int J Mol Sci. 2025 May 14;26(10):4673. doi: 10.3390/ijms26104673.
2
Efficiency of Skeletal Muscle Mass/Weight Measurement for Distinguishing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Analysis Using InBody Bioimpedance Devices.骨骼肌质量/重量测量在鉴别代谢功能障碍相关脂肪性肝病中的效能:一项使用InBody生物电阻抗设备的前瞻性分析
Nutrients. 2024 Dec 23;16(24):4422. doi: 10.3390/nu16244422.
3
Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review.

本文引用的文献

1
Defining sarcopenia: some caveats and challenges.定义肌肉减少症:一些注意事项和挑战。
Curr Opin Clin Nutr Metab Care. 2020 Mar;23(2):127-132. doi: 10.1097/MCO.0000000000000621.
2
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.肌肉减少症与2型糖尿病男性的非酒精性脂肪性肝病有关。
Diabetes Metab. 2020 Oct;46(5):362-369. doi: 10.1016/j.diabet.2019.10.004. Epub 2019 Nov 2.
3
Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study.
非酒精性脂肪性肝病中肌肉减少症的临床特征:一项系统性综述。
Obes Facts. 2025;18(1):72-85. doi: 10.1159/000541650. Epub 2024 Oct 16.
4
Serum Creatinine as an Independent Predictor of Moderate to Severe Fibrosis in Chinese American Non-obese Metabolic Dysfunction-Associated Steatotic Liver Disease.血清肌酐作为华裔美国人非肥胖代谢功能障碍相关脂肪性肝病中重度纤维化的独立预测指标
Cureus. 2024 May 26;16(5):e61116. doi: 10.7759/cureus.61116. eCollection 2024 May.
5
The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review.非酒精性脂肪性肝病和肌少症的非药物和新兴药物治疗管理的作用:一篇叙述性综述。
J ASEAN Fed Endocr Soc. 2024;39(1):84-94. doi: 10.15605/jafes.039.01.04. Epub 2023 Oct 27.
6
Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.性别对代谢相关脂肪性肝病患者骨骼肌量的影响:基于倾向评分匹配研究。
J Nutr Health Aging. 2024 Jun;28(6):100270. doi: 10.1016/j.jnha.2024.100270. Epub 2024 Jun 3.
7
Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis.非酒精性脂肪性肝病与肌少症风险的关联:系统评价和荟萃分析。
BMJ Open. 2024 May 6;14(5):e078933. doi: 10.1136/bmjopen-2023-078933.
8
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肌肉减少症的患病率及预后
World J Gastrointest Pathophysiol. 2024 Apr 22;15(1):91100. doi: 10.4291/wjgp.v15.i1.91100.
9
Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.非酒精性脂肪性肝病中肌少症及其定义成分的患病率因评估和调整方法而异:来自英国生物库的研究结果。
Calcif Tissue Int. 2024 Jun;114(6):592-602. doi: 10.1007/s00223-024-01212-5. Epub 2024 Apr 28.
10
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease.肌肉力量与非酒精性脂肪性肝病/代谢相关脂肪性肝病。
World J Gastroenterol. 2024 Feb 21;30(7):636-643. doi: 10.3748/wjg.v30.i7.636.
非酒精性脂肪性肝病老年患者握力降低:一项基于全国人口的研究。
Aging (Albany NY). 2019 Jul 7;11(13):4547-4560. doi: 10.18632/aging.102068.
4
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
5
Aerobic capacity and exercise performance in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的有氧能力与运动表现
J Sports Med Phys Fitness. 2019 Aug;59(8):1376-1388. doi: 10.23736/S0022-4707.19.09231-4. Epub 2019 Feb 12.
6
Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing.性别特异性肌少症发病风险因素:英国老龄化纵向研究 8 年随访
J Epidemiol Community Health. 2019 Jan;73(1):86-88. doi: 10.1136/jech-2018-211258. Epub 2018 Oct 27.
7
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.老年人肌少症性肥胖:病因、流行病学和治疗策略。
Nat Rev Endocrinol. 2018 Sep;14(9):513-537. doi: 10.1038/s41574-018-0062-9.
8
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.骨骼肌量与非酒精性脂肪性肝病的关系:一项 7 年纵向研究。
Hepatology. 2018 Nov;68(5):1755-1768. doi: 10.1002/hep.30049. Epub 2018 Oct 14.
9
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).代谢综合征的各个组成部分会增加非酒精性脂肪性肝病(NAFLD)的死亡风险。
Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214.
10
Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.血清睾酮与美国男女性非酒精性脂肪肝
Liver Int. 2018 Nov;38(11):2051-2059. doi: 10.1111/liv.13735. Epub 2018 Mar 31.